Stowell Cheri, Wang Lin, Arbogast Brian, Lan Jing-Quan, Cioffi George A, Burgoyne Claude F, Zhou An
Robert S. Dow Neurobiology Laboratories, Legacy Research, Portland, OR.
Int J Physiol Pathophysiol Pharmacol. 2010 Jun 30;2(2):148-160.
In retina, an ischemic injury-resistant condition (ischemic tolerance) can be induced by a sub-lethal ischemic treatment (preconditioning) prior to an otherwise injurious ischemic insult. In this work, we compared retinal proteomic changes under three different ischemic conditions, as a means to identify the effector mechanisms that underlie retinal ischemic tolerance. Transient retinal ischemia was induced by elevating the intraocular pressure (IOP) in three groups of adult rats as follows: Group 1, ischemic-preconditioned, 110 mmHg for 8 minutes followed by 48 hours reperfusion; Group 2, ischemic-injured, 110 mmHg for 60 minutes followed by 24 hours reperfusion; Group 3, ischemic-tolerant, preconditioning treatment followed by another 60 minutes of 110 mmHg and 24 hours reperfusion. Protein quantities in each of the afore-mentioned retinal ischemic conditions, as determined by quantitative mass spectrometry, were compared with that of the contralateral control eyes (sham-treated). As a result, a total of 328 proteins were identified and quantified; among them, 30-60% of proteins showed a change in abundance under one or more retinal ischemic conditions. In particular, in ischemic-tolerant retinas, histone proteins H2B, H3 and H4 demonstrated an increase in abundance, whereas histone H2A showed a decrease in abundance. Further immunohistochemical analyses confirmed the results of proteomic analyses, and detected an up regulation of tri-methylated histone H3, mono-ubiquitinated histone H2A and Polycomb group protein RING2. Together, these results suggest a role of epigenetic regulation in the induction of retinal ischemic tolerance that involves histone and polycomb proteins.
在视网膜中,一种抗缺血损伤的状态(缺血耐受)可通过在具有损伤性的缺血性损伤之前进行亚致死性缺血处理(预处理)来诱导。在这项研究中,我们比较了三种不同缺血条件下视网膜蛋白质组的变化,以此来确定视网膜缺血耐受背后的效应机制。通过升高三组成年大鼠的眼压来诱导短暂性视网膜缺血,具体如下:第1组,缺血预处理组,眼压110 mmHg持续8分钟,随后再灌注48小时;第2组,缺血损伤组,眼压110 mmHg持续60分钟,随后再灌注24小时;第3组,缺血耐受组,先进行预处理,然后再以110 mmHg持续60分钟并再灌注24小时。通过定量质谱法测定上述每种视网膜缺血条件下的蛋白质含量,并与对侧对照眼(假手术处理)进行比较。结果,共鉴定和定量了328种蛋白质;其中,30 - 60%的蛋白质在一种或多种视网膜缺血条件下丰度发生了变化。特别是,在缺血耐受的视网膜中,组蛋白H2B、H3和H4的丰度增加,而组蛋白H2A的丰度降低。进一步的免疫组织化学分析证实了蛋白质组学分析的结果,并检测到三甲基化组蛋白H3、单泛素化组蛋白H2A和多梳蛋白RING2的上调。这些结果共同表明,表观遗传调控在涉及组蛋白和多梳蛋白的视网膜缺血耐受诱导中发挥作用。